{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:31:14Z","timestamp":1786120274533,"version":"build-2736575974"},"reference-count":44,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1097\/ftd.0b013e318239a41a","type":"journal-article","created":{"date-parts":[[2011,11,19]],"date-time":"2011-11-19T04:27:49Z","timestamp":1321676869000},"page":"757-765","source":"Crossref","is-referenced-by-count":20,"title":["An Enzymatic Method to Determine \u03b3-Hydroxybutyric Acid in Serum and Urine"],"prefix":"10.1097","volume":"33","author":[{"given":"Lara","family":"Hasan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas M","family":"Jermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jakob M","family":"Weber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Abrahamsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel-Angelo","family":"Sciotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"B\u00f6ttcher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"J\u00f6chle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Gygax","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9","family":"Scholer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-14-20210129","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0741-8329(99)00090-7","article-title":"Abuse and therapeutic potential of gamma-hydroxybutyric acid.","volume":"20","author":"Galloway","year":"2000","journal-title":"Alcohol"},{"key":"R2-14-20210129","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1080\/10550490500419144","article-title":"Club drug use among youths in treatment for substance abuse.","volume":"15","author":"Hopfer","year":"2006","journal-title":"Am J Addict"},{"key":"R4-14-20210129","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1007\/s00216-003-1896-z","article-title":"Analytical developments in toxicological investigation of drug-facilitated sexual assault.","volume":"376","author":"Negrusz","year":"2003","journal-title":"Anal Bioanal Chem"},{"key":"R5-14-20210129","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.forsciint.2005.02.014","article-title":"The presence of gamma-hydroxybutyric acid (GHB) and gamma-butyrolactone (GBL) in alcoholic and non-alcoholic beverages.","volume":"151","author":"Elliott","year":"2005","journal-title":"Forensic Sci Int"},{"key":"R6-14-20210129","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1177\/0897190007305149","article-title":"The neuropharmacology of sleep disorders: better sleeping through chemistry?","volume":"20","author":"Suhl","year":"2007","journal-title":"J Pharm Pract"},{"key":"R7-14-20210129","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1177\/0269881108094620","article-title":"Incidence of craving for and abuse of gamma-hydroxybutyric acid (GHB) in different populations of treated alcoholics: an open comparative study.","volume":"23","author":"Caputo","year":"2009","journal-title":"J Psychopharmacol"},{"key":"R8-14-20210129","doi-asserted-by":"crossref","first-page":"993","DOI":"10.2165\/00023210-200620120-00004","article-title":"Gamma-hydroxybutyrate\/sodium oxybate: neurobiology, and impact on sleep and wakefulness.","volume":"20","author":"Pardi","year":"2006","journal-title":"CNS Drugs"},{"key":"R9-14-20210129","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1517\/14728214.2010.491509","article-title":"Emerging therapies for fibromyalgia: an update.","volume":"15","author":"Ablin","year":"2010","journal-title":"Expert Opin Emerg Drugs"},{"key":"R10-14-20210129","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.ajem.2009.11.008","article-title":"Case series of 226 -hydroxybutyrate-associated deaths: lethal toxicity and trauma.","volume":"29","author":"Zvosec","year":"2011","journal-title":"Am J Emerg Med"},{"key":"R11-14-20210129","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s00213-008-1160-5","article-title":"Cataleptic effects of gamma-hydroxybutyrate (GHB) and baclofen in mice: mediation by GABA(B) receptors, but differential enhancement by N-methyl-d-aspartate (NMDA) receptor antagonists.","volume":"199","author":"Koek","year":"2008","journal-title":"Psychopharmacology (Berl)"},{"key":"R12-14-20210129","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S0301-0082(96)00064-0","article-title":"The gamma-hydroxybutyrate signalling system in brain: organization and functional implications.","volume":"51","author":"Maitre","year":"1997","journal-title":"Prog Neurobiol"},{"key":"R13-14-20210129","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1093\/jat\/28.8.625","article-title":"Pharmacokinetics and excretion of gamma-hydroxybutyrate (GHB) in healthy subjects.","volume":"28","author":"Brenneisen","year":"2004","journal-title":"J Anal Toxicol"},{"key":"R14-14-20210129","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1093\/jat\/30.6.360","article-title":"3rd, et al. GHB urine concentrations after single-dose administration in humans.","volume":"30","author":"Haller","year":"2006","journal-title":"J Anal Toxicol"},{"key":"R15-14-20210129","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.neuroscience.2004.11.021","article-title":"Gamma-hydroxybutyric acid (GHB) and the mesoaccumbens reward circuit: evidence for GABA(B) receptor-mediated effects.","volume":"131","author":"Pistis","year":"2005","journal-title":"Neuroscience"},{"key":"R16-14-20210129","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/S0196-0644(98)70232-X","article-title":"A tale of novel intoxication: a review of the effects of gamma-hydroxybutyric acid with recommendations for management.","volume":"31","author":"Li","year":"1998","journal-title":"Ann Emerg Med"},{"key":"R17-14-20210129","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1197\/aemj.9.7.730","article-title":"2nd. Gamma hydroxybutyric acid (GHB) intoxication.","volume":"9","author":"Mason","year":"2002","journal-title":"Acad Emerg Med"},{"key":"R18-14-20210129","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1111\/j.1399-6576.2010.02278.x","article-title":"Twenty-three deaths with gamma-hydroxybutyrate overdose in western Sweden between 2000 and 2007.","volume":"54","author":"Knudsen","year":"2010","journal-title":"Acta Anaesthesiol Scand"},{"key":"R19-14-20210129","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.sleep.2009.01.005","article-title":"Three deaths associated with use of Xyrem.","volume":"10","author":"Zvosec","year":"2009","journal-title":"Sleep Med"},{"key":"R20-14-20210129","doi-asserted-by":"crossref","first-page":"45","DOI":"10.2165\/00139709-200423010-00005","article-title":"The gamma-hydroxybutyrate withdrawal syndrome.","volume":"23","author":"Tarabar","year":"2004","journal-title":"Toxicol Rev"},{"key":"R21-14-20210129","first-page":"3","article-title":"Clinical features and management of gamma-hydroxybutyrate (GHB) withdrawal: a review. Drug Alcohol Depend.","volume":"75","author":"McDonough","year":"15","journal-title":""},{"key":"R22-14-20210129","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1093\/jat\/32.4.298","article-title":"A rapid GC-MS determination of gamma-hydroxybutyrate in saliva.","volume":"32","author":"De Paoli","year":"2008","journal-title":"J Anal Toxicol"},{"key":"R23-14-20210129","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1093\/jat\/30.6.375","article-title":"GC-MS-MS determination of gamma-hydroxybutyrate in blood and urine.","volume":"30","author":"Paul","year":"2006","journal-title":"J Anal Toxicol"},{"key":"R24-14-20210129","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1021\/ac048471h","article-title":"GC\/MS profiling of gamma-hydroxybutyrate and precursors in various animal tissues using automatic solid-phase extraction. Preliminary investigations of its potential interest in postmortem interval determination.","volume":"77","author":"Richard","year":"2005","journal-title":"Anal Chem"},{"key":"R26-14-20210129","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.chroma.2004.04.067","article-title":"Simultaneous analysis of gamma-hydroxybutyric acid and its precursors in urine.","volume":"1056","author":"Wood","year":"2004","journal-title":"J Chromatogr A"},{"key":"R27-14-20210129","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0021-9673(02)01704-1","article-title":"Determination of -hydroxybutyric acid in human urine by capillary electrophoresis with indirect UV detection and confirmation with electrospray ionization ion-trap mass spectrometry.","volume":"990","author":"Baldacci","year":"2003","journal-title":"J Chromatogr A"},{"key":"R28-14-20210129","first-page":"486","article-title":"Ion chromatographic determination of GHB in serum and urine.","volume":"25","author":"Jordi","year":"2003","journal-title":"Ther Drug Monit"},{"key":"R29-14-20210129","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1520\/JFS2003165","article-title":"Reliable, sensitive, rapid and quantitative enzyme-based assay for gamma-hydroxybutyric acid (GHB).","volume":"49","author":"Bravo","year":"2004","journal-title":"J Forensic Sci"},{"key":"R30-14-20210129","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/S0379-0738(02)00050-6","article-title":"2nd, Ng K. Rapid colorimetric screening test for gamma-hydroxybutyric acid (liquid X) in human urine.","volume":"126","author":"Alston","year":"2002","journal-title":"Forensic Sci Int"},{"key":"R31-14-20210129","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1097\/00007691-199906000-00023","article-title":"Rapid screening test for gamma-hydroxybutyric acid (GHB, Fantasy) in urine.","volume":"21","author":"Badcock","year":"1999","journal-title":"Ther Drug Monit"},{"key":"R32-14-20210129","doi-asserted-by":"crossref","first-page":"793","DOI":"10.2533\/chimia.2010.793","article-title":"Development and characterization of an enzymatic method for the rapid determination of gamma hydroxybutyric acid.","volume":"64","author":"Sciotti","year":"2010","journal-title":"Chimia"},{"key":"R33-14-20210129","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","article-title":"A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.","volume":"72","author":"Bradford","year":"1976","journal-title":"Anal Biochem"},{"key":"R36-14-20210129","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1093\/jat\/18.6.357","article-title":"Driving under the influence of GHB.","volume":"18","author":"Stephens","year":"1994","journal-title":"J Anal Toxicol"},{"key":"R37-14-20210129","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1093\/jat\/24.6.421","article-title":"Analysis of biofluids for gamma-hydroxybutyrate (GHB) and gamma hydroxybutyrolactone (GBL) by headspace GC-FID and GC-MS.","volume":"24","author":"LeBeau","year":"2000","journal-title":"J Anal Toxicol"},{"key":"R38-14-20210129","first-page":"709","article-title":"A new biometrical procedure for testing the equality of measurements from two different analytical methods. Application of linear regression procedures for method comparison studies in clinical chemistry, part I.","volume":"21","author":"Passing","year":"1983","journal-title":"J Clin Chem Clin Biochem"},{"key":"R39-14-20210129","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0140-6736(86)90837-8","article-title":"Statistical methods for assessing agreement between two methods of clinical measurement.","volume":"i","author":"Bland","year":"1986","journal-title":"Lancet"},{"key":"R42-14-20210129","first-page":"80","article-title":"Es besteht Veranlassung, den Entscheidungswert zur Differenzierung endo\/exogener GHBBlutspiegel auf 1 g\/ml abzusenken.","volume":"75","author":"Steinecke","year":"2008","journal-title":"T+K"},{"key":"R43-14-20210129","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.forsciint.2006.08.007","article-title":"Further evidence of in vitro production of gamma-hydroxybutyrate (GHB) in urine samples.","volume":"169","author":"LeBeau","year":"2007","journal-title":"Forensic Sci Int"},{"key":"R44-14-20210129","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.forsciint.2010.03.035","article-title":"Gamma-hydroxybutyrate in urine and serum: additional data supporting current cut-off recommendations.","volume":"200","author":"Andresen","year":"2010","journal-title":"Forensic Sci Int"},{"key":"R45-14-20210129","first-page":"171","article-title":"Urinary endogenous concentrations of GHB and its isomers in healthy humans and diabetics.","volume":"149","author":"Shima","year":"2005","journal-title":"For Sci Int"},{"key":"R46-14-20210129","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1210\/jcem-54-3-665","article-title":"Elevated plasma beta-hydroxybutyrate concentrations without ketonuria in healthy insulin-dependent diabetic patients.","volume":"54","author":"McGillivray","year":"1982","journal-title":"J Clin Endocrinol Metab"},{"key":"R47-14-20210129","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1136\/bmj.2.5813.565","article-title":"Rapid blood ketone body estimation in the diagnosis of diabetic ketoacidosis.","volume":"2","author":"Alberti","year":"1972","journal-title":"Br Med J"},{"key":"R48-14-20210129","doi-asserted-by":"crossref","first-page":"433","DOI":"10.2337\/diab.23.5.433","article-title":"Clinical studies of alcoholic ketoacidosis.","volume":"23","author":"Cooperman","year":"1974","journal-title":"Diabetes"},{"key":"R50-14-20210129","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1093\/clinchem\/35.5.837","article-title":"Unreliable visual estimation of the incidence and amount of turbidity, hemolysis, and icterus in serum from hospitalized patients.","volume":"35","author":"Glick","year":"1989","journal-title":"Clin Chem"},{"key":"R51-14-20210129","first-page":"31","article-title":"The influence of bilirubin, hemolysis and turbidity on 20 analytical tests performed on automatic analysers.","volume":"33","author":"Grafmeyer","year":"1995","journal-title":"Eur J Clin Chem Clin Biochem"}],"container-title":["Therapeutic Drug Monitoring"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/FTD.0b013e318239a41a","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T20:23:28Z","timestamp":1786047808000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00007691-201112000-00014"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12]]},"references-count":44,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1097\/ftd.0b013e318239a41a","relation":{},"ISSN":["0163-4356"],"issn-type":[{"value":"0163-4356","type":"print"}],"subject":[],"published":{"date-parts":[[2011,12]]}}}